rs199554089
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000642.3(AGL):c.2486A>G(p.Asn829Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000899 in 1,613,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000642.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGL | NM_000642.3 | c.2486A>G | p.Asn829Ser | missense_variant | Exon 19 of 34 | ENST00000361915.8 | NP_000633.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000721 AC: 18AN: 249620Hom.: 0 AF XY: 0.0000886 AC XY: 12AN XY: 135440
GnomAD4 exome AF: 0.0000931 AC: 136AN: 1461346Hom.: 0 Cov.: 32 AF XY: 0.0000880 AC XY: 64AN XY: 726964
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74408
ClinVar
Submissions by phenotype
Glycogen storage disease type III Uncertain:3
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 829 of the AGL protein (p.Asn829Ser). This variant is present in population databases (rs199554089, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with AGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 424411). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
not provided Uncertain:2
The N829S variant in the AGL gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The N829S variant is observed in 19/126082 (0.015%) alleles from individuals of non-Finnish European background in large population cohorts (Lek et al., 2016). The N829S variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret N829S as a variant of uncertain significance. -
BP4 -
Inborn genetic diseases Uncertain:1
The c.2486A>G (p.N829S) alteration is located in exon 19 (coding exon 18) of the AGL gene. This alteration results from a A to G substitution at nucleotide position 2486, causing the asparagine (N) at amino acid position 829 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at